UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of Putnam Associates, a US-based strategic management healthcare consultancy and Incisive Health, a UK-based healthcare policy and communications consultancy. Both focussed within the Healthcare industry, Putnam strengthens Ashfield’s growing advisory pillar, adding significant expertise in product commercialisation, pricing, reimbursement and market access strategy. Incisive Health adds specialist capability in the growing area of public health advocacy, supporting clients to secure marketing access for their brands, in addition to wider communications services.
Based in the US, Putnam is a specialist consultancy focused on product commercialisation strategy, exclusively for the life sciences industry. Founded in 1988, Putnam has grown to become a respected advisory brand for biopharmaceutical companies, and attracts top class talent from several of the leading US universities. With 120 employees across offices in Boston and San Francisco, Putnam primarily offers consultancy services across the product life cycle with particular strengths in product commercialisation, pricing and reimbursement and market access strategy. Over the past 10 years, Putnam has advised on the commercialisation of several products that have achieved blockbuster sales status in the US.
Putnam adds significant capabilities and scale to Ashfield’s existing advisory pillar in the US as well as delivering a step change in Ashfield’s capabilities in pricing, reimbursement and market access. Putnam also complements Ashfield’s existing advisory offering, including STEM, Vynamic and SmartAnalyst, which were acquired between 2016 and 2018.
Commenting on the acquisition of Putnam, Rob Wood, President of Ashfield Advisory Services and Global Business Development, said:
“The acquisition of Putnam Associates significantly strengthens and enhances UDG Healthcare’s capabilities, adding expertise in product commercialisation, pricing, reimbursement and market access strategy.
Putnam is a strong strategic and cultural fit for UDG Healthcare, expanding and enriching the capabilities that we provide to our clients. Putnam’s expertise from working in the life sciences industry for over 30 years will be invaluable as we continue to grow our organisation”.
Incisive Health is a UK-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services. Across its head office in London and an office in Brussels, the consultancy employs 36 people and provides a suite of consultancy and communications services including clinical advocacy, corporate and digital communications, direct payer engagement, public affairs, stakeholder campaigning, strategic and policy development and training programmes. Incisive Health has a diversified client base of predominately pharmaceutical and biotech companies.
Incisive Health significantly strengthens Ashfield Communications’ capabilities in the UK and mainland Europe, specifically in dedicated policy and market access communications.
Commenting on the acquisition of Incisive Health, Richard Lawrence, Executive Director, Ashfield Healthcare Communications, said:
“We are delighted by the addition of Incisive Health to the UDG Healthcare and Ashfield family as they bring a rare set of best in class insights and capabilities in the policy space. On top of this, Incisive Health are a strong cultural fit for Ashfield Healthcare Communications. The acquisition will provide both organisations, our clients and our colleagues with new expertise, capabilities and opportunities.
The acquisition enhances our capabilities to support clients at every stage of the product lifecycle and manage the complex markets they operate in. Incisive Health will specifically complement our existing and award winning offering in PR and healthcare communications provided by Galliard/Nyxeon, who focus on scientific storytelling, and Pegasus who create integrated communications campaigns that change behaviour across different healthcare markets. Put together, this acquisition would see us top the latest PR Week healthcare league table.”